BERNHARDT LABORATORIES INC NPI 1417960626

NPI Information

  • NPI: 1417960626
  • Provider Name: BERNHARDT LABORATORIES INC
  • Classification: Clinical Medical Laboratory - 291U00000X
  • Entity Type: Organization
  • Address: 3728 PHILIPS HWY STE 64
    JACKSONVILLE, FL
    ZIP 32207
  • Phone: (904) 296-2333

Map and Directions

Get Directions

NPI Details

BERNHARDT LABORATORIES INC is a clinical medical laboratory in Jacksonville, FL. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. BERNHARDT LABORATORIES INC NPI is 1417960626. The provider is registered as an organization entity type.

The provider's business location address is:

3728 PHILIPS HWY STE 64
JACKSONVILLE, FL
ZIP 32207-898
Phone: (904) 296-2333
Fax: (904) 296-8467

The provider's authorized official is Dina Valladares .
The authorized official title is Director, Credentialing & Pe and has the following contact phone number (561) 514-5822.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
  • Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (HCPCS:G0145)
  • Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
  • Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
  • Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
  • Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
  • Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
  • Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)
  • Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
  • Detection test by nucleic acid for herpes simplex virus, amplified probe technique (HCPCS:87529)
  • Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
  • Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician (HCPCS:G0124)
  • Pap test (HCPCS:88141)
  • Gene analysis (t cell antigen receptor beta) amplification methodology (HCPCS:81340)
  • Gene rearrangement analysis detection abnormal clonal population (t cell antigen receptor gamma) (HCPCS:81342)
  • Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
  • Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
  • Surgical pathology consultation and report on referred slides prepared elsewhere (HCPCS:88321)
  • Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
  • Test for detecting genes associated with cancer (HCPCS:81455)
  • Detection of mycoplasma genitalium by dna or rna probe (HCPCS:87563)
  • Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only (HCPCS:87625)
  • Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
  • Pathology examination of tissue using a microscope, moderately high complexity (HCPCS:88307)
  • Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
  • Microsatellite instability analysis (HCPCS:81301)
  • Gene rearrangement analysis (immunoglobulin heavy chain locus) to detect abnormal clonal population amplified methodology (HCPCS:81261)
  • Gene rearrangement analysis (immunoglobulin kappa light chain locus) to detect abnormal clonal population (HCPCS:81264)
  • Microscopic genetic analysis of tumor, manual (HCPCS:88360)
  • Test for detecting genes associated with colon cancer, promoter methylation analysis (HCPCS:81288)
  • Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
  • Surgical pathology consultation and report on referred material requiring preparation of slides (HCPCS:88323)
  • Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (HCPCS:G0476)
  • Test for detecting genes associated with cancer of body organ (HCPCS:81445)

The enumeration date for this NPI number is 8/15/2006 and was last updated on 10/15/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1291U00000XClinical Medical Laboratory800001509FLORIDAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1002263700MEDICAIDFLORIDA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.